Tokyo court rejects Shire claim against Roche haemophilia drug

Chugai, which is 60 percent Roche-owned and which developed Hemlibra, said it expected no change to its financial prospects due to the ruling. “Tokyo District Court rendered a decision in favour of Chugai’s claim,” Chugai said on its website. “(Shire’s …
( read original story …)


Related Post

Japan activates first marines since WW2 to bolster...
views 93
SASEBO/TOKYO, Japan (Reuters) - Japan on Saturday ...
Here’s Who Really Matters at the Bank of Japan: Da...
views 93
In the Japanese context, where monetary policy is ...
Tokyo down again as Asian markets end volatile yea...
views 167
Tokyo retreated again Friday despite Toshiba's sha...
Japan protests dessert to be served to North Korea...
views 54
Japan filed a protest on Tuesday with South Korea,...
Calling card: the evolution of business cards in J...
views 183
Another theory suggests that Commodore Matthew C. ...
Japan rejects calls to invest in bullet train
views 180
Thailand wants Japan to invest in the Shinkansen-l...
United ending flights to Sapporo, Palau route
views 140
United Airlines announced last week that it will t...
Japan, China take uneasy step toward warmer ties
views 204
TOKYO -- Relations between Japan and China are fin...
Japan finmin: New farm spending should lift effici...
views 192
TOKYO, July 14 (Reuters) - Any fresh government sp...
Abe: Japan planning for refugees in event of Korea...
views 195
On Friday, the NSC members discussed how to deal w...